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Introduction: Despite overall improvement, there is still a gender-related disparity in the outcomes of lower extremities
peripheral arterial disease (PAD). We analyzed sex-related variability among factors that are known to influence outcomes.
Methods: Data on PAD inpatient hospitalizations from New York, New Jersey, and Florida state hospital discharge
databases (1998-2007) were analyzed using univariate and multivariate logistic regression analyses.
Results: Of the 372,692 surgical hospitalizations identified, 162,730 (43.66%) involved women. Men and women
undergoing vascular procedures differed in that more men smoked (18% vs 14%; P< .0001), and more men had coronary
artery disease (40% vs 33%; P< .0001).Womenwere more likely to be obese (11.86% vs 4.89%; P<.0001), black (18.81%
vs 12.66%; P < .0001), older, and have critical limb ischemia (CLI) (39.41% vs 37.67%; P < .0001). They had higher
mortality (5.26% vs 4.21%; P < .0001) and complication rates, especially bleeding (10.62 % vs 8.19%; P < .0001) and
infection (3.23% vs 2.88%; P < .0001). Mortality rates after endovascular procedures were lower and showed marginal
difference between genders (2.87% vs 2.11%; P < .0001). The difference was more pronounced after open revascular-
izations (5.05% for women vs 4.00% for men; P <.0001) and amputations (9.82% for women vs 8.82% for men; P <
.0001). Bleeding differences between men and women were greatest when both open and endovascular procedures were
done during the same hospitalizations and lowest after major amputations. Similar to bleeding, transgender differences
in postoperative infections were more pronounced after combination of open and endovascular procedures. Using a
multivariable model, female gender remained a predictor of perioperative mortality, infection, and bleeding after vascular
intervention (odds ratios 1.15, 1.21, and 1.32, respectively). Female gender negatively influenced the mortality of
patients with cerebrovascular and coronary disease and those of black race even after adjusting for relevant clinical and
demographic risk factors. Gender effect on mortality dissipated in octogenarians and patients with claudication.
Conclusion: Female gender continues to be an important risk factor that negatively influences the outcomes of vascular
interventions; however, these effects vary between different high-risk groups and procedures. Gender effect on mortality
dissipates in elderly patients. Prompt recognition of the associations between gender and various risk factors of
cardiovascular disease and aggressive modification of these risk factors in female patients may improve gender-related
disparity in the outcomes of vascular disease. ( J Vasc Surg 2010;52:1196-1203.)The development of new techniques in vascular surgery
has revolutionized the management of vascular disease over
the last decade by decreasing the complication rates and
mortality associated with vascular procedures and allowing
vascular interventionalists to offer limb salvage procedures
to patients that were not candidates for open interventions
because of excessive risk. These technological advances
have had substantial impact on the functional outcome of
patients and will continue to impact on the quality of life of
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1196the continuously growing elderly population of the United
States and Western societies. The majority of this elderly
population are women who outnumber men over 75 by a
ratio of 3:2 and those over 80 by 2:1 (http://wonder.cdc.
gov/population.html).
Contrary to historical misperception, elderly women
are at comparable risk to elderly men for developing vascu-
lar disease, presumably because they are deprived from the
atheroprotective effect of female hormones in the post-
menopausal years.1,2 In fact, many recent reports have
demonstrated equal prevalence of peripheral arterial disease
(PAD) in men and women with rates in women that
actually exceed those seen in men for those in their 70s or
80s.3,4
In a recent paper,5 we analyzed trends in vascular
procedures by gender from 1998 to 2007 using data from
three states with large populations at risk for PAD: New
York, New Jersey, and Florida. We found that women with
PAD were more likely to be admitted emergently for this
disease but less likely to undergo open procedures than
male counterparts. However, endovascular procedures for
PAD were used proportionately in men and women, and
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increase in usage was associated with a reduction in treat-
ment-related mortality for both men and women. How-
ever, absolute mortality rates were consistently higher for
women.
The purpose of this article was to identify and compare
risk factors for men and women that affect the outcomes of
different surgical treatments for PAD. Specifically, we eval-
uated the effect of female gender as a risk factor for mor-
tality, and perioperative complications in different patient
groups such as octogenarians, and patients with renal, cardio-
vascular, cerebrovascular disease, and diabetes. Moreover, we
analyzed factors that portend poor outcome separately inmen
and women and identified gender-related variability.
METHODS
Source of data and population selection. We ana-
lyzed the state inpatient discharge databases of New York,
New Jersey, and Florida for a 10-year period (1998
through 2007). These three states were selected because
they offered the highest volume of hospitalizations of the
states that disclose gender-related information. We in-
cluded all hospitalizations with the diagnosis of lower ex-
tremity PAD (ICD9-based) in which a lower extremity
revascularization (LER, open or endovascular) and/or a
major amputation was performed.
The data were obtained from the following state agen-
cies: New York State Health Department’s Statewide Plan-
ning and Research Cooperative System (SPARCS), New
Jersey’s Department of Health and Senior Service, and the
Florida State’s Department of Health. The datasets did not
include patient identification to protect patient confidenti-
ality.
Hospitalizations with diagnosis code (primary or sec-
ondary positions) 440.21 were categorized as admission for
claudication, and those with diagnosis codes indicating rest
pain (440.22), ulceration (440.23), or gangrene (440.24,
707.1 or 707.9) were categorized as admissions for
critical ischemia. Treatment groups were identified by
cross-referencing relevant procedure codes with diagnosis
codes. The following treatment groups were analyzed:
open lower extremity revascularization (ICD9 procedure
codes 38.08, 38.18, 38.38, 38.48, or 39.29), endovascular
lower extremity revascularization (39.50 or 39.90), and
major lower limb amputation (84.13-84.17). The clinical
subgroups of patients with diabetes, renal disease, coronary
artery disease (CAD), cerebrovascular disease, claudication,
and critical limb ischemia (CLI) were identified in each
treatment group by ICD9 codes. The diagnosis and proce-
dure code groupings and linkages were selected based on
methodology from prior studies.5,6 Because of the low
prevalence of PADs in patients younger than 40, we ex-
cluded them from the analysis.
Annual state census information was obtained from the
Center for Disease Control and Prevention Wonder tool
and was used for per capita calculations (http://wonder.
cdc.gov/population.html).Statistics. We used Student t test for univariate analy-
sis of continuous variables and 2 test for dichotomous
variables. The associations between mortality and gender
and between operative complications (infection and bleed-
ing) and gender were both analyzed by multivariable
logistic regression modeling, controlling for age, type of
procedure, baseline comorbidities, and year of procedure.
Additional regression analyses were conducted for the fol-
lowing subgroups: patients with claudication, CLI, cardiac
arterial disease, diabetes (DM), cerebrovascular (CVA) and
renal disease, octogenarians, and blacks. Statistical signifi-
cance was expressed as both P values and 95% confidence
intervals (CIs). Values of P  .05 were considered signifi-
cant. Data were analyzed using SAS version 9.13 (SAS
Institute, Cary, NC).
RESULTS
There were 372,692 hospitalizations in which at least
one procedure for PAD was performed. Procedures were
performed more often on men (56%) than women (44%).
Table I summarizes the demographic characteristics, co-
Table I. Demographic and baseline comorbid
characteristics of patients who underwent vascular
procedures for lower extremity peripheral arterial disease
in New York, New Jersey, and Florida during 1998-
2007, stratified by gender
Women
(N  162,730)
Men
(N  209,962) P value
Demographics
White 69.85% 75.77% .0001
Black 18.81% 12.66% .0001
Hispanic 7.28% 7.42% .0912
Native American 0.25% 0.28% .0466
Asian 0.62% 0.63% .7139
Other race 0.88% 0.89% .8058
Mean age, years 72 69 .0001
Comorbidities
DM 41.47% 43.44% .0001
HTN 61.73% 57.39% .0001
COPD 19.70% 20.85% .0001
CAD 32.93% 39.65% .0001
Renal 15.45% 16.80% .0001
CVA 6.85% 5.92% .0001
Lipids 10.42% 10.91% .0001
Smoking 13.62% 18.15% .0001
Obesity 11.86% 4.89% .0001
Critical ischemia 39.41% 37.67% .0001
Claudication 9.42% 11.51% .0001
Insurance
Medicare 78.38 72.40 .0001
Medicaid 6.16 5.99 .0001
Commercial 13.17 18.22 .0001
Workers
Compensation
0.08 0.29 .0001
Uninsured 1.45 2.07 .0001
Other insurance 0.76 1.03 .0001
CAD, Coronary artery disease; COPD, chronic obstructive pulmonary dis-
ease; CVA, cerebrovascular accident; DM, diabetes; HTN, hypertension.
Shaded areas designate statistically higher rates.morbid conditions, symptoms on presentation, and insur-
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appear to be different: women on average were older; the
mean age for women was 72 and for men, 69 years (P 
.0001). Women were more likely to be black, have hyper-
tension (HTN) and cerebrovascular disease, and at least
twice as likely to be obese than men. They were also more
likely to be treated for CLI. Men, on the other hand, were
more likely to be white, smokers, and had a higher preva-
lence of chronic obstructive pulmonary disease (COPD),
DM, CAD, and renal disease.
There was a very small percentage of uninsured patients
and the difference between men and women, although
statistically significant was numerically marginal (1.45 in
women vs 2.07 in men; P  .0001).
Postoperative complications. Comparison of imme-
diate outcomes after intervention is shown in Table II.
Women had notably higher rates of bleeding (10.6% vs
8.2%; P  .0001) and postoperative mortality (5.26% vs
4.21%; P .0001) and weremore likely to undergo amajor
leg amputation during a LER hospitalization (24.9% vs
23.4%; P .0001) than men. Fig 1 depicts postoperative
Table II. Postoperative complications and mortality after
vascular procedures for lower extremity peripheral arterial
disease by gender
Women Men P value
Cardiac 2.26% 2.18% .1076
PO stroke 0.30% 0.22% .0001
Respiratory 2.66% 2.48% .0006
Bleeding 10.62% 8.19% .0001
Infections 3.23% 2.88% .0001
Shock 0.20% 0.14% .0001
Major amputations 24.92% 23.35% .0001
Open and endo LER 6.21% 6.45% .0035
Death 5.26% 4.21% .0001
LER, Lower extremity revascularization; PO stroke, postoperative stroke.
Shaded areas designate statistically higher rates.
Fig 1. Postoperative bleeding by procedure type and gender.
Endo, Endovascular revascularization; LER, lower extremity
revascularization; major, major amputations; open, open revas-
cularization.bleeding by procedure type. Bleeding wasmore common inwomen than men for all of the procedures studied. The
difference was greatest for hospitalizations in which both
open and endovascular procedures were performed
(15.74% vs 10.92%; P .0001). Bleeding was also more
common in women for all clinical subgroups studied (Fig
2). The most pronounced difference between men and
women in bleeding complications was observed in patients
with claudication, cerebrovascular disease, and CAD. After
controlling for baseline comorbid conditions, patient age,
type, and year of procedure, female gender increased risk of
bleeding by 33% (odds ratio [OR], 1.33, 95% confidence
limits [CL], 1.30-1.36; P  .0001).
Overall, women had a higher risk of perioperative in-
fection (3.23% vs 2.88%; P .0001). However, the level of
risk and the gender difference varied by procedure (Fig 3).
The highest risk and the greatest difference was observed in
those patients who had both open and endovascular LER
procedures during the same admission (10.83% vs 8.88%,
1.95%; P .0002). On the other hand, the lowest infection
rate with no gender-related difference was seen after endo-
Fig 2. Postoperative bleeding after vascular procedures for differ-
ent clinical subsets of patients with lower extremity peripheral
arterial disease by gender. CAD, Coronary arterial disease; Claud,
claudication;Cr. Isch, critical ischemia;DM, diabetes. * P .0001.
Fig 3. Gender difference in postoperative infections by proce-
dure type. Endo, Endovascular revascularization; LER, lower
extremity revascularization; major, major amputations; open,
open revascularization.vascular procedures (1.21% vs 1.05%; P  .421). When
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operative infection rates and greatest gender differences
were seen in patients with renal disease (5.51% vs 4.20%;
P  .0001) (Fig 4). Transgender difference in infection
rates was not statistically significant in octogenarians, pa-
tients with coronary artery disease, cerebrovascular disease,
and claudication. Overall, female gender was an indepen-
dent predictor of postprocedural infection, increasing the
risk for infection by 21% in multivariable analysis (OR,
1.21; 95% CL, 1.17-1.26; P  .0001).
Gender andmortality. As noted, overall mortality for
all PAD procedures was 1.1% higher for women than men.
Even after adjusting for clinical and demographic covari-
ates, women had a 15% higher risk of dying (OR, 1.15; 95
CL, 1.11-1.18; P  0.0001). Fig 5 breaks down mortality
by procedure type. The risk of mortality was higher for
women for all of the procedures studied. The risk was
highest for hospitalizations in which both a lower extremity
revascularization and amputation were performed (14.32%
vs 12.41%; P  .0002). The greatest gender-related differ-
ence in mortality, 2.1%, occurred during hospitalizations in
which both open and endovascular LER procedures were
Fig 4. Postoperative infections by clinical subsets of patients and
gender. CAD, Coronary arterial disease; Claud, claudication; Cr
Isch, critical ischemia; DM, diabetes. * P  .0001.
Fig 5. In-hospital mortality by procedure type and gender.
Endo LER, Endovascular lower extremity revascularization;ma-
jor amp, major amputation; open LER, open lower extremity
revascularization.performed. The mortality rate and gender difference waslowest (0.5%) for hospitalizations in which an endovascular
procedure was performed (1.97% vs 1.46%; P .0002).
Fig 6 breaks down mortality by comorbid condition,
demographic factors, and gender. Among the comorbid
conditions evaluated, renal disease was associated with the
highest risk of inpatient mortality for both men and women
(9.44% in women vs 8.15% in men; P  .0001). The
difference in mortality between genders was greatest for
patients with cerebrovascular disease (1.62% higher in
women; P  .04), followed closely by patients with race
designation black (1.43% higher in women; P  .03). The
smallest transgender differences were observed for patients
older than age 80 (0.4% higher in women; P  .008).
After adjustment for patient demographic, baseline co-
morbidities, type, and year of procedure and clinical pre-
sentation of PAD, gender differences in mortality persisted
(Table III). For patients with cerebrovascular disease, fe-
male gender increased the risk of hospital mortality by 33%.
For patients with coronary artery disease, the increase was
21% and for patients of black race, the increase was 20%.We
observed significant age-related variability on mortality
with mortality increasing substantially as age progresses.
Fig 6. In-hospital mortality after surgical procedures for different
clinical subsets of patients with lower extremity peripheral arterial
disease by gender. CAD, Coronary artery disease; Claud, claudi-
cation; Cr Isch, critical ischemia; DM, diabetes.
Table III. Female gender as a mortality risk factor in
clinical subsets of patients after adjustment for baseline
comorbidities, age, type of procedure, and year when the
procedure was performed
OR 95% CL OR P value
Cerebrovascular 1.33 1.17-1.51 .0001
CAD 1.21 1.12-1.30 .0001
Black 1.20 1.11-1.30 .0001
Diabetics 1.14 1.08-1.21 .0001
Renal 1.13 1.07-1.20 .0001
Critical ischemia 1.11 1.06-1.17 .0001
Claudication 1.25 0.97-1.60 .0886
Octogenarian 1.05 0.99-1.10 .1194
Results are based onmultivariable regression analysis. Odds ratios (OR) with
corresponding 95% confidence limits (CL) are presented.Furthermore, there were significant interactions between
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and older age (70 years) had protective effect against
periprocedural mortality. This was not seen in younger
ages (Table IV).
DISCUSSION
Within the last decade, there has been an increased
awareness of vascular disease in women. Women account
for the majority of the aging Western population, and the
prevalence of vascular disease in elderly women is quite
substantial. In fact, according to several epidemiologic
studies, it equals the prevalence of vascular disease in
men.1,2 However, the diagnosis and treatment of vascular
disease in women is often delayed and associated with
significant challenges. One of the first findings of this article
was a fairly recurrent observation7,8 that women are more
likely than men to be treated for advanced PAD associated
with CLI (Table I). The reasons for this are not well
understood, but certain speculations can be made. The
early symptoms and signs of PAD in women may go unno-
ticed, because there is an established bias in society and
among physicians that women do not get atherosclerotic
disease. This is in part true for young women during the
reproductive years when hormonal and metabolic factors
are causing an atheroprotective physiologic environ-
ment.9,10 However, elderly women are deprived from this
beneficial effect of reproductive hormones11 and are at least
as likely as men to develop atherosclerotic disease.3,4 There
are also other possible factors that do not allow prompt
medical treatment of vascular disease in women. Elderly
women with PAD are more likely thanmen to live alone, be
isolated or live in extended care facilities (http://www.
cdc.gov/nchs/data/ad/ad311.pdf) or care for an even
older and more disabled spouse and, therefore, often ne-
Table IV. Interaction between gender and age groups
and its effect on mortality
Factor OR 95% CL OR P value
Age 40-44 0.65 0.52-0.82 .0003
Age 45-49 0.79 0.67-0.93 .0048
Age 50-64 - control
Age 65-69 1.44 1.32-1.56 .0001
Age 70-74 1.65 1.53-1.78 .0001
Age 75-79 1.95 1.81-2.10 .0001
Age 80-84 2.31 2.13-2.48 .0001
Age 85 2.91 2.68-3.15 .0001
Female gender 1.34 1.22-1.50 .0001
Interaction with
female gender
Female*Age 40-44 0.88 0.62-1.26 .4816
Female*Age 45-49 0.98 0.76-1.26 .8761
Female*Age 65-69 0.94 0.83-1.06 .3226
Female*Age 70-74 0.88 0.78-0.99 .0263
Female*Age 75-79 0.89 0.79-0.99 .0292
Female*Age 80-84 0.87 0.78-0.96 .0161
Female*Age 85 0.84 0.75-0.94 .0024
CL, Confidence limits; OR, odds ratios.
Based on results of multivariable logistic regression analysis.glect their own symptoms.12-16 Our analysis did not showcritical discrepancy in insurance status between men and
women that could have contributed in the delayed diagno-
sis of PAD in women. Data regarding differences in income
and poverty rates between men and women was not avail-
able in this database and, therefore, were not analyzed.
However, data from AARP16 have shown significantly
lower income and higher poverty rates in elderly women
compared with men. Lower income rates are associated
with more advanced PAD and 1.4-fold increase in amputa-
tion rates compared with higher-income patients.17 Finally,
symptoms related to arterial disease in elderly women are
often masked by those related to osteoporosis or degener-
ative joint disease, which are also prevalent in this particular
group of patients.18,19
The effect of gender on the outcomes of vascular
disease is not well understood. Small, single-institution
trials have shown conflicting results regarding short- and
long-term results of open vascular procedures in men and
women,20-25 and for the outcomes of endovascular proce-
dures, the literature is both conflicting and sparse. In some
of those reports, women appeared to have equivalent out-
comes to men,8,26 while in others they were worse.27,28
Most were inadequately powered to make specific gender
comparisons, which is a disadvantage that statewide dis-
charge datasets do not suffer from.
Our analysis of the discharge data fromNew York, New
Jersey, and Florida over the last 10 years demonstrated that
mortality rates for women undergoing surgical interven-
tions for PAD remain substantially higher than that of men
even after adjusting for coexisting diseases. The difference
in observed mortality between men and women was the
highest in the setting of cerebrovascular disease. In this
setting, women had a 33% higher risk of mortality thanmen
even after adjustment for other relevant risk factors. For
patients with underlying coronary artery disease, the ad-
justed difference in risk was 21%. Interestingly, advanced
age alone dissipates the negative effect of female gender on
periprocedural mortality. As shown in Table III, gender
had no negative effect on mortality in octogenarians. Ad-
ditionally, there were significant interactions between age
and gender that influence mortality: female gender and
older age (70 years) had protective effect against
periprocedural mortality. This was not seen in younger
ages (Table IV).
One possible explanation for the above observations is
that a natural selection process has taken place, ie, fewer
women at higher risk survived into their late 70s and 80s.
This contrasts with observations made in other groups of
women with comorbidities such as cerebrovascular and
cardiovascular disease. In fact, these women are likely to
represent a more assorted population with comorbidities
not as well recognized and aggressively optimized when
compared with their male counterparts. Indeed, literature
suggests that cardiovascular disease in women is often
under diagnosed.29 Furthermore, preventive strategies
against cerebrovascular or cardiovascular disease are unde-
rutilized in women. One example comes from data from
the first national screening program for carotid disease that
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2002-2003. Interestingly, in this program, women with
50% or more carotid stenosis were less likely than men to be
on antiplatelet treatment (32% women vs 56% men; P 
.0006).7 It is also known that women with coronary arterial
disease are less frequently managed with lipid-lowering
medications and beta-blockers.30,31 Such suboptimal med-
ical management may, in part, explain why female gender
increased the risk of periprocedural mortality by 33% and
21% in patients with cerebrovascular and cardiovascular
disease in our study.
In looking at the adverse events that potentially under-
lie the differences in mortality risk observed between men
and women, we found women had significantly higher rates
of both periprocedural bleeding and infection (Table II).
Particularly with bleeding complications, these were more
frequent in women after both open and endovascular re-
constructions (Fig 1). The same finding was previously
observed for coronary revascularization.32-34,35,36 One
possible explanation is a difference in the pharmacokinetics
of heparin in women.37-39 Women tend to metabolize
heparin slower, even after correcting for age and weight
differences. In fact, one study demonstrated that, despite
strict weight-based dosing, women were at higher risk of
aPTT overshoot.39 This would fit with our finding of only
a marginal difference in bleeding for major amputation, as
this procedure, in general, is performed without systemic
anticoagulation. Due to this latter finding, other systemic
causes such as accentuated bleeding diathesis in women
secondary to factor deficiency or more frequent use of
antiplatelet or other chronic anticoagulation treatment are
also quite unlikely. This speculation is unverifiable by the
dataset used in this paper. Finally, whether other technical
and anatomic factors such as smaller arteries and use of
relatively large, for the female anatomy, devices during
open or endovascular procedures play an additional role in
the incidence of postoperative bleeding in women is un-
clear and unanswerable with statewide discharge databases
and, clearly, warrants further investigation using primary
data collection.
We also observed a higher rate of periprocedural infec-
tions in women after open reconstructions, major amputa-
tions, and a combination of open and endovascular recon-
structions (Fig 3). In fact, female gender increased the odds
of infection by 21%. This observation agrees with prior
studies that demonstrated higher rates of wound complica-
tions in women compared to men.20,21,40 Although the
increased risk in these studies may be attributable to a
higher prevalence of diabetes, others have identified female
gender as an independent predictor of wound complica-
tions.41,42 The biologic basis for such discrepancy in infec-
tion rates has not been fully elucidated but may include
differences in metabolism, fat content and fat distribution,
particularly in the upper thighs and abdomen. Of note,
there was no difference between men and women in post-
operative infection after endovascular procedures, and the
overall infection rate after such procedures was very low
(1.21% vs 1.05%, ns).As stated previously in other papers,5,6 analyses of large
administrative datasets have several limitations. In addition
to biases due to missing, inaccurate, or incomplete dis-
charge summaries, they, in general, do not contain patient
identifiers, precluding longitudinal follow-up. As such, we
can only report here on in-hospital mortality and compli-
cation rates and not longer follow-up rates such as 30 days
and 1 year, which are more informative. Finally, the data-
base does not include information on outpatient proce-
dures, which may account for a significant percentage of
overall interventions. Nevertheless, as stated earlier, the size
of the statewide discharge administrative datasets provides
the statistical power needed to make comparison between
demographic and clinically relevant subgroups. Conse-
quently, they are used widely for that purpose.
CONCLUSION
In conclusion, the outcomes of treatment of lower
extremity PAD outcomes have improved over time in both
men and women. However, women continue to experience
higher rates of mortality and morbidity than their male
counterpart after vascular interventions. These differences
vary in different high-risk groups and clinical settings.
Moreover, female gender associated with increased risk of
mortality at variable intensity in different clinical subsets
but not in octogenarians where, in fact, it has a protective
effect. A better understanding, analysis, and consideration
of these associations between gender and other risk factors,
may correct gender-related disparity in the outcomes of
vascular procedures.
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Dr Vouyouka and colleagues are to be commended for their
important contribution to the literature entitled: “Lessons learned
outcomes of lower extremity peripheral arterial disease”. The
influence of gender on peripheral arterial disease (PAD) is not well
studied and is not well defined in the current literature. Unfortu-
